Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-040769
Filing Date
2025-03-18
Accepted
2025-03-18 08:00:04
Documents
2
Period of Report
2025-03-10

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1539
2 EX-24.1 itrm-ex24_1.htm EX-24.1 11603
  Complete submission text file 0000950170-25-040769.txt   14735
Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Issuer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ITERUM THERAPEUTICS PLC 3 DUBLIN LANDINGS, NORTH WALL QUAY DUBLIN L2 D01 H104
Business Address
Whalen Joseph John (Reporting) CIK: 0002060246 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38503 | Film No.: 25746514